Market Overview:
The global skin cancer therapeutics market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to factors such as increasing incidence of skin cancer, rising awareness about early diagnosis and treatment of skin cancer, and technological advancements in the field of skin cancer therapeutics. Based on type, the global skin cancer therapeutics market is segmented into chemotherapy, radiotherapy, cryosurgery, immune therapy, photodynamic therapy (PDT), surgery, and other treatments. Chemotherapy is expected to be the fastest-growing segment during the forecast period owing to its high efficacy in treating various types of cancers including melanoma and basal cell carcinoma (BCC). PDT is also expected to grow at a high rate during the forecast period due its ability to target specific cells without causing any damage to healthy tissues around them. Based on application, the global skin cancer therapeutics market is segmented into hospitals, clinics,, research centers,, and others..
Product Definition:
Skin cancer therapeutics are the drugs and treatments used to cure or manage skin cancer. Skin cancer is the most common type of cancer in the United States, and it can be deadly if not treated. Early diagnosis and treatment of skin cancer is important for a successful outcome.
Chemotherapy:
Chemotherapy is a group of medical drugs or therapy used to treat cancer. The major types of chemotherapy include alkylating agents, cytotoxic agents, plant derivatives, and antimetabolites. Alkylating agents block the biosynthesis of RNA and DNA in cells leading to cell death; cytotoxicagents kill cells by causing cell damage; while antimetabolites act as anti-tumor antibiotics by inhibiting the synthesisof nucleic acids in tumor cells.
Radiotherapy:
Radiotherapy is a form of cancer treatment in which high doses of ionizing radiation are used to fight the cancer. The most common types of cancers that are treated with radiotherapy include skin, prostate, and breast cancers. According to the American Cancer Society (ACS), in 2018, about 2 million new cases were diagnosed globally and around 609,640 people died due to this disease.
Application Insights:
Skin cancer is divided into two categories, namely malignant and non-malignant. The incidence rate of non-malignant skin tumors in the U.S. is approximately 2% to 4%, while that of malignant skin tumor is around 14%. According to the American Cancer Society, an estimated 80% of all cancers are caused by factors such as genetics, environment, and lifestyle habits.
The most common types of skin cancer are basal cell carcinoma (BCC), squamous cell carcinoma (SCC), melanoma,.
Regional Analysis:
North America dominated the global skin cancer therapeutics market in 2017. This can be attributed to the high incidence of skin cancer, increasing adoption of innovative technologies and presence of well-established healthcare facilities in this region. In addition, rising awareness about early diagnosis is expected to fuel growth during the forecast period. Asia Pacific is anticipated to witness lucrative growth over the coming years owing to improving healthcare infrastructure and growing patient awareness levels pertaining treatment options for skin cancers.
Major players operating in this space include BAYER AG; Merck Group; Celgene Corporation; Pfizer Inc.; FUJIFILM Diosynth Biotechnologies Co., Ltd.; Amgen Inc.; AbbVie Inc.; Eisai Co., Ltd.; Aracare Therapeutics LLC; Ono Pharmaceutical Co.
Growth Factors:
- Increasing incidence of skin cancer
- Growing awareness about skin cancer and its prevention measures
- Rising demand for better and more effective treatment options for skin cancer
- Technological advancements in the field of skin cancer therapeutics
- increasing investments by pharmaceutical companies in research and development of new drugs for the treatment of skin cancer
Scope Of The Report
Report Attributes
Report Details
Report Title
Skin Cancer Therapeutics Market Research Report
By Type
Chemotherapy, Radiotherapy, Cryosurgery, Immune Therapy, Photodynamic Therapy, Surgery, Other Treatments
By Application
Hospital, Clinic, Cancer Research Center, Others
By Companies
Pfizer, Merck, Novartis, GlaxoSmithKline, Bristol Myers Squibb, Eli Lilly, Roche, Qiagen, Boehringer Ingelheim, Aqua Pharmaceuticals, Meda, Elekta AB, Varian Medical Systems, Bausch Health
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
219
Number of Tables & Figures
154
Customization Available
Yes, the report can be customized as per your need.
Global Skin Cancer Therapeutics Market Report Segments:
The global Skin Cancer Therapeutics market is segmented on the basis of:
Types
Chemotherapy, Radiotherapy, Cryosurgery, Immune Therapy, Photodynamic Therapy, Surgery, Other Treatments
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Cancer Research Center, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Merck
- Novartis
- GlaxoSmithKline
- Bristol Myers Squibb
- Eli Lilly
- Roche
- Qiagen
- Boehringer Ingelheim
- Aqua Pharmaceuticals
- Meda
- Elekta AB
- Varian Medical Systems
- Bausch Health
Highlights of The Skin Cancer Therapeutics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Chemotherapy
- Radiotherapy
- Cryosurgery
- Immune Therapy
- Photodynamic Therapy
- Surgery
- Other Treatments
- By Application:
- Hospital
- Clinic
- Cancer Research Center
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Skin Cancer Therapeutics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Skin cancer therapeutics is a field of pharmaceutical research and development that focuses on the discovery, development, and commercialization of new treatments for skin cancer.
Some of the major companies in the skin cancer therapeutics market are Pfizer, Merck, Novartis, GlaxoSmithKline, Bristol Myers Squibb, Eli Lilly, Roche, Qiagen, Boehringer Ingelheim, Aqua Pharmaceuticals, Meda, Elekta AB, Varian Medical Systems, Bausch Health.
The skin cancer therapeutics market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Skin Cancer Therapeutics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Skin Cancer Therapeutics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Skin Cancer Therapeutics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Skin Cancer Therapeutics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Skin Cancer Therapeutics Market Size & Forecast, 2020-2028
4.5.1 Skin Cancer Therapeutics Market Size and Y-o-Y Growth
4.5.2 Skin Cancer Therapeutics Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Chemotherapy
5.2.2 Radiotherapy
5.2.3 Cryosurgery
5.2.4 Immune Therapy
5.2.5 Photodynamic Therapy
5.2.6 Surgery
5.2.7 Other Treatments
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Cancer Research Center
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Skin Cancer Therapeutics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Skin Cancer Therapeutics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Chemotherapy
9.6.2 Radiotherapy
9.6.3 Cryosurgery
9.6.4 Immune Therapy
9.6.5 Photodynamic Therapy
9.6.6 Surgery
9.6.7 Other Treatments
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Cancer Research Center
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Chemotherapy
10.6.2 Radiotherapy
10.6.3 Cryosurgery
10.6.4 Immune Therapy
10.6.5 Photodynamic Therapy
10.6.6 Surgery
10.6.7 Other Treatments
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Cancer Research Center
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Chemotherapy
11.6.2 Radiotherapy
11.6.3 Cryosurgery
11.6.4 Immune Therapy
11.6.5 Photodynamic Therapy
11.6.6 Surgery
11.6.7 Other Treatments
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Cancer Research Center
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Chemotherapy
12.6.2 Radiotherapy
12.6.3 Cryosurgery
12.6.4 Immune Therapy
12.6.5 Photodynamic Therapy
12.6.6 Surgery
12.6.7 Other Treatments
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Cancer Research Center
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Chemotherapy
13.6.2 Radiotherapy
13.6.3 Cryosurgery
13.6.4 Immune Therapy
13.6.5 Photodynamic Therapy
13.6.6 Surgery
13.6.7 Other Treatments
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Cancer Research Center
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Skin Cancer Therapeutics Market: Competitive Dashboard
14.2 Global Skin Cancer Therapeutics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 Merck
14.3.3 Novartis
14.3.4 GlaxoSmithKline
14.3.5 Bristol Myers Squibb
14.3.6 Eli Lilly
14.3.7 Roche
14.3.8 Qiagen
14.3.9 Boehringer Ingelheim
14.3.10 Aqua Pharmaceuticals
14.3.11 Meda
14.3.12 Elekta AB
14.3.13 Varian Medical Systems
14.3.14 Bausch Health
